CVS Group’s (CVSG) Buy Rating Reaffirmed at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reissued their buy rating on shares of CVS Group (LON:CVSG) in a report released on Monday, MarketBeat.com reports. The firm currently has a GBX 1,700 target price on the stock.

CVSG has been the subject of several other research reports. Berenberg Bank reiterated a “buy” rating and issued a GBX 2,000 target price on shares of CVS Group in a report on Thursday, July 23rd. Jefferies Financial Group downgraded CVS Group to a “hold” rating and cut their price target for the stock from GBX 1,420 to GBX 1,350 in a report on Thursday, July 9th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of GBX 1,710.

CVS Group Price Performance

CVSG stock opened at GBX 1,233 on Monday. The business has a fifty day moving average of GBX 1,224.34 and a two-hundred day moving average of GBX 1,246.49. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 92.34. The stock has a market cap of £853.24 million, a price-to-earnings ratio of 17.90, a price-to-earnings-growth ratio of 1.77 and a beta of 1.06. CVS Group has a 52-week low of GBX 1,062 and a 52-week high of GBX 1,648.

CVS Group announced that its board has authorized a share buyback plan on Tuesday, May 26th that allows the company to repurchase 0 outstanding shares. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its shares are undervalued.

Insider Transactions at CVS Group

In other CVS Group news, insider Scott Morrison acquired 987 shares of the stock in a transaction dated Wednesday, May 27th. The stock was acquired at an average cost of GBX 1,270 per share, with a total value of £12,534.90. 1.43% of the stock is owned by company insiders.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.